Artivion, Inc., headquartered in suburban Atlanta, Georgia, will acquire Israel-based Endospan, a developer of solutions for the end ...
Stryker announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), which is developing a next-genera ...
Rapid Medical announced full results from the DISTALS randomized clinical trial demonstrating that the company’s Tigertriever ...
Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common ...
Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon ...
Teleflex Incorporated announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8 ...
Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...
A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results